Whole-genome CRISPR Screening of stably expressing Cas9 Cancer Organoid Lines

Charlotte Beaver, Tessa Fowler, Jade Smith, Adam Jackson, Agnieszka Andres, Emily Souster, Hazel Rogers, Alexandra Beck, Mathew Garnett

Published: 2024-04-15 DOI: 10.17504/protocols.io.3byl4q6zrvo5/v1

Abstract

This protocol is for whole-genome CRISPR screening of stably expressing Cas9 cancer organoid lines in triplicate using the commercially available minimal genome-wide human CRISPR Cas9 library. The protocol uses lentiviral transduction as a method for gRNA delivery. This method can be adapted for other gRNA libraries.

The protocol can be followed assuming the following is known:

  • The number of days required for screening

  • The size of the gRNA library

  • The required coverage of the library

To allow for efficient scale up of the organoid culture for screen, a 5% suspension culture method can be used. This is not essential to be able to perform whole-genome CRISPR screening of stably expressing Cas9 cancer organoid lines, but provides a more scalable, ergonomic and cost efficient culturing method.

Prior to commencing the screen a puromycin antibiotic titration is used to identify the most suitable puromycin concentration for the selection of Cas9 positive cancer organoid lines transduced with gRNA library virus.

A gRNA library titration is then performed to determine the volume of library virus required to transduce Cas9 cancer cells at 30% transduction efficiency which is calculated using FACS analysis. This is to avoid host cells taking up more than one gRNA copy per cell, therefore an MOI of 30% should be aimed for.

Process Diagram

Process diagram outlining key steps for CRISPR-Cas9 screening in organoids.
Process diagram outlining key steps for CRISPR-Cas9 screening in organoids.

This protocol uses a 21-23 day screen process.

Before start

Prior to each process, pre-warm culture media to room-temperature.* Where required, prepare an aliquot of 1mg/ml puromycin (working concentration) by diluting a 10mg/ml stock 1:10 with sterile water.

  • On Day 4 of the puromycin titration process, bring Cell Titer-Glo 2.0 reagent to room temperature. (It is light-sensitive and so it is advisable to keep the reagent covered at all times to avoid exposure to light when using).
  • Prior to gRNA library transduction, thaw an aliquot of (10mg/ml) polybrene
  • Where required, thaw the required volume of lentivirus for each process stage.
  • When fixing organoids, dilute 37% formaldehyde solution 1:10 with DPBS and store at 4°C

Steps

Puromycin titration

1.

Day 1: Titration plate set up

Note
This assay is set up using previously expanded organoids which are stably expressing Cas9.

1.1.

Pre-warm organoid specific culture media to room temperature.

1.10.

Resuspend 2.4x106 cells in 2.7 ml of organoid specific culture media + 300µL BME2 (this will give a final seeding density of 8x104 cells per well once plated, Rows B-G of Fig 1).

1.11.

Prepare a control stock solution containing organoid specific culture media with 5% BME2 (Row A of Fig 1).

1.12.

Set up the titration plate as detailed in Fig 1 below;

Fig 1: Puromycin titration plate set upRow A = 200 µl control stock solution per well (step 1.11)Rows B - G = 100 µl cell suspension (step 1.10)
Fig 1: Puromycin titration plate set upRow A = 200 µl control stock solution per well (step 1.11)Rows B - G = 100 µl cell suspension (step 1.10)

Note
Always seed 3 wells per Row as the titration is carried out in triplicate.A 96-well plate can be used to titrate up to 4 cell lines at a time.

1.13.

Incubate the plate at 37°C 5% CO2 for 0h 10m 0s to allow the BME2 to polymerise.

1.14.

Using a 1 mg/ml stock, prepare puromycin antibiotic solutions at 2x concentrations in organoid specific culture media in 5 ml tubes as outlined below. (Table 1).

Safety information
Puromycin is toxic if swallowed and harmful in contact with skin.

Table 1: 2x puromycin concentrations using 1mg/ml puromycin stock.
Table 1: 2x puromycin concentrations using 1mg/ml puromycin stock.

Note
Prepare a minimum of 2.5 ml of each 2x antibiotic so that the volume is adequate for loading a multi-channel pipette without bubbles. Antibiotic dilutions should be prepared fresh on the day that they are required.

1.15.

Remove the plate from the incubator and pipette 100µL of the relevant 2x puromycin stock into each well (Rows B-G) to achieve the final require puromycin concentration according to the plate layout in Fig 1.

1.16.

Incubate the plate for 72h 0m 0s at 37°C 5% CO2.

1.17.

Plate any remaining cells from step 1.10 into a 5% BME2 suspension culture by seeding cells into a solution of 19mL organoid specific culture media + 1mLBME2 using an ultra-low attachment T75 flask.

Note
A minimum of 10x106cells are required at this stage.

1.18.

Incubate the ultra-low attachment T75 flask at 37°C 5% CO2.

Note
The seeded ultra-low attachment T75 flask is to be used for gRNA library titration set up (see section 3).

1.2.

Aspirate media from each well of the organoid culture plate plate and add 2mL TrypLE to each well.

1.3.

Using a cell-scraper detach BME2 drops containing the cancer organoids from the plate and transfer the organoid suspension to an appropriately sized tube.

1.4.

Pipette the suspension up and down multiple times to dissociate organoids from the BME2.

1.5.

Incubate at 37°C 5% CO2.

1.6.

Check the organoid suspension under the microscope every 15 minutes to assess and

monitor the dissociation of the organoids. Mix the suspension thoroughly prior to each check to help dissociate the organoids.

Note
Generally the suspension becomes cloudy once the majority of organoids are dissociated to small clumps of cells. Stop the incubation once the organoids have broken down to single cells.

1.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

1.8.

Aspirate the supernatant and resuspend the pellet in an 10 ml of organoid specific culture media.

1.9.

Perform a cell count to calculate the total number of cells.

Note
A minimum of 12.5 x106 cells are required at this stage to ensure enough cells remain for transfer to 5% BME2 suspension culture (step 1.17).

2.

Day 4: Assessing cell viability using CellTiter-Glo

2.1.

Thaw CellTiter-Glo 2.0 reagent and equilibrate to room-temperature prior to use.

Safety information
CellTiter-Glo is harmful to aquatic life with long lasting effects.

Note
CellTiter-Glo reagent can be stored at -20 °C and is stable for up to 4 freeze-thaws; thawed reagent can be kept at 4 °C for up to 5 months.CellTiter-Glo is light-sensitive so should be kept covered, and used in a cell culture hood with the light off where possible.

2.2.

Run a CellTiter-Glo 2.0 viability assay following the manufacturer’s instructions.

celltiterglo-2-0-assay-protocol.pdf

Note
This process dilutes the reagent 1:5 rather than 1:2 with the cell suspension. It is recommended by the manufacturer to use white plates. However, the luciferase signal was found to be too strong so using black plates is recommended.

2.3.

Using the luminescence data plot a kill curve to ascertain the lowest concentration of puromycin which results in approximately 100% cell death after 72 hours. (Fig 2).

Note
To create the kill curve;- Average the triplicate luminescence values to get a single value for each condition.- Subtract the average background luminescence (Row A, media only) from the other averaged conditions (Rows B-G).- Divide the average luminescence minus background for each concentration 1, 2, 3, 4 and 5 µg/ml by the 0 µg/ml average to obtain a relative percentage viability.- Plot these percentage viabilities on a graph.

Citation
Fig 2: Example kill curve showing a 'kill concentration' of 3 µg/ml.
Fig 2: Example kill curve showing a 'kill concentration' of 3 µg/ml.

Guide RNA library titration of Cas9 expressing organoid lines

3.

Day 1: gRNA library titration set up

3.1.

Pre-warm organoid specific culture media to room temperature and thaw a 10 mg/ml aliquot of polybrene.

3.10.

Perform a cell count to calculate the total number of cells.

3.11.

Prepare a preparation mix using the cell suspension and transduction media to achieve a final concentration of 5.6x106 cells in a total volume of 11.2mLplus 14µL 10 mg/ml polybrene.

Note
This protocol provides the volumes required to set up a 6 point titration, plus 1 well of dead volume, seeding 8x105cells/well with a final polybrene concentration of 10µg/ml. If more or less points are required adjust volumes accordingly.

3.12.

Transfer 1.6 ml of the preparation mix to 6x bioreactor tubes (8x105 cells per tube) and add relevant transduction media volumes. (see media volume in Table 2).

Table 2: Library titration example volumes.
Table 2: Library titration example volumes.
3.13.

Thaw an aliquot of the gRNA library to room temperature. If the gRNA library is not being used

neat, dilute the required volume of the gRNA library in organoid complete culture media.

Note
Any dilution made to the library at this stage will also need to be made when carrying out the gRNA library transduction at screen.Once defrosted, the gRNA library should be used within 1 hour.Avoid freeze/thaw cycles of the gRNA library.

Safety information
Lentiviral vectors can infect human cells. Ensure correct use of PPE and utilise recommended waste routes to reduce the risk.

3.14.

Add the appropriate volume of gRNA library virus (Table 2) to each bioreactor tube.

3.15.

Mix well by pipetting and transfer the bioreactor tubes to the incubator at 37°C 5% CO2 for

overnight incubation.

3.16.

Passage all remaining organoids in 5% BME2 organoid specific suspension culture media.

Note
The passaged organoids are to be used for gRNA library transduction set up (see section 6).

3.2.

Prepare transduction media, by adding 12.5µL of 10millimolar (mM) Y-27632 (Rock inhibitor) to 50mL organoid specific culture media (2.5micromolar (µM) final concentration).

Note
Cells need to remain in transduction media throughout this protocol.

3.3.

Collect the organoid suspension culture (from step 1.18) in a 50 ml tube and centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

3.4.

Aspirate the supernatant and resuspend the pellet in 15 ml to 20 ml of TrypLE.

3.5.

Pipette the suspension up and down multiple times to dissociate organoids from the BME2.

3.6.

Incubate at 37°C 5% CO2.

3.7.

Check the organoid suspension under the microscope every 15 minutes to assess and

monitor the dissociation of the organoids. Mix the suspension thoroughly prior to each check to help dissociate the organoids.

Note
Generally the suspension becomes cloudy once the majority of organoids are dissociated to small clumps of cells. Stop the incubation once the organoids have broken down to single cell.

3.8.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

3.9.

Aspirate the supernatant and resuspend the pellet in an appropriate volume of transduction media.

Note
15-20 ml is advised.

4.

Day 2: Plating

4.1.

Transfer the 6x bioreactor tubes to the centrifuge ensuring the centrifuge bucket lid is

secure.

Safety information
Lentiviral vectors can infect human cells. Ensure correct use of PPE and utilise recommended waste routes to reduce the risk.To reduce the risk of aerosols, it is advised where possible that centrifuge buckets are sealed using safety caps and only opened in a microbiological safety cabinet.

4.2.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

4.3.

Aspirate the supernatant from the tubes and resuspend each cell pellet in1.9mL of transduction media (prepared on Day 1) and add 100µL of 100% BME2 to make a 5% BME2 solution. Mix well and transfer all 2 ml into each well of a low attachment 6wp. (Fig 3).

Fig 3: Example plate layout. Titration concentrations can be adjusted.
Fig 3: Example plate layout. Titration concentrations can be adjusted.
4.4.

Incubate at 37°C 5% CO2 until Day 6.

Formaldehyde fixation of organoids

5.

Day 6: Fixing and staining organoids for flow cytometry analysis.

5.1.

Prepare Live/Dead stain solution or antibodies.

Note
This protocol uses an e780 viability dye. For this reagent prepare a 1:10,000 dilution of e780 dye in PBS. Mix well and store at 4°C (Solution can be used for 1 week from the time it was prepared).

5.10.

Add 1mL PBS to each tube

5.11.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

5.12.

Aspirate supernatant and resuspend in 500µL of 3.7% formaldehyde. Mix well by pipetting to ensure cells are fixed as single cells.

Safety information
3.7% formaldehyde must be prepared and used only in a chemical fume hood, using chemical resistant gloves. Waste must be kept in the fume hood and disposed of via the recommended route.

5.13.

Incubate at 4°C for 0h 10m 0s.

5.14.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

5.15.

Carefully aspirate supernatant (in chemical fume hood).

Note
Cell pellets may become transparent and therefore difficult to see. It may also be sticky so can easily stick to pipette tips.

5.16.

Resuspend the pellet in 500µL (dependent on pellet size) PBS or alternative FACs buffer, and store at 4°C until ready for analysis by flow cytometry.

5.17.

Using collected flow cytometry data create a plot showing side scatter area vs BFP+ expression, gating the positively expressed BFP+ cells.

5.18.

For each titration point create an overlay plot (Fig 4) using your un-transduced control (Well 1 of Fig 3).

Citation
Fig 4: Example flow cytometry analysis of %BFP expression. Blue = tested virus concentration. Red = e780 un-transduced control.
Fig 4: Example flow cytometry analysis of %BFP expression. Blue = tested virus concentration. Red = e780 un-transduced control.

5.19.

Using the %BFP expression for each titration point, plot a titration curve to calculate the volume of virus required to obtain 30% BFP expression. (Fig 5).

Note
A 30% transduction efficiency is aimed for to try and ensure that each host cell has only taken up one copy of the gRNA library.

Citation
Fig 5: Example gRNA library titration curve. For 30% BFP expression a volume of 41 µl of virus per 2ml would be required.
Fig 5: Example gRNA library titration curve. For 30% BFP expression a volume of 41 µl of virus per 2ml would be required.

5.2.

Collect the suspension culture from each well of the ultra-low attachment 6wp into individual 2 ml tubes.

5.3.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

5.4.

Aspirate the supernatant and resuspend in 1mL of Trypsin-EDTA (0.25%).

Safety information
May cause allergy or asthma symptoms or breathing difficulties if inhaled.

5.5.

Incubate for 0h 15m 0s, until organoids have broken down to single cells.

Note
Mix the solution every few minutes during the incubation. Some lines take longer to dissociate. Do not leave any longer than 30 minutes.

5.6.

Once organoids have broken down to single cells stop the reaction by adding 1mL (diluting 1:1) of media containing serum.

5.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

5.8.

Aspirate supernatant and resuspend pellets in 200µL Live/Dead dye solution (or specific antibody of choice).

5.9.

For the Live/Dead solution, incubate at room temperature for 0h 5m 0s. (Follow specific guidelines for your antibodies).

Guide RNA Library transduction and screen of Cas9 expressing organoid lines

6.

Day 1: gRNA library transduction

6.1.

Pre-warm organoid specific culture media to room temperature. Thaw a 10 mg/ml aliquot of polybrene and a 10millimolar (mM) aliquot of Y-27632 (Rock inhibitor).

6.10.

Thaw an aliquot of the gRNA library to room temperature. If the gRNA library is not being used

neat, dilute the required volume of the gRNA library in organoid complete culture media.

Note
Any dilution made to the library at this stage must match the dilution carried out when setting up the gRNA library titration.Once defrosted, the gRNA library should be used within 1 hour.Avoid freeze/thaw cycles of the gRNA library.

Safety information
Lentiviral vectors can infect human cells. Ensure correct use of PPE and utilise recommended waste routes to reduce the risk.

6.11.

Carry out each library transduction in triplicate. Prepare each replicate in a 250 ml erlenmeyer flask as per Table 3. Mix gently by pipetting.

Note
This protocol using the Minimal genome-wide human CRISPR Cas9 library requires 12.5x106 cells per replicate at transduction.
Table 3: Replicate transduction mixture set up for Minimal genome-wide human CRISPR Cas9 library. The volume of library virus required to obtain 30% transduction efficiency will be previously established following library titration and scaled to account for transduction labware size at screen.
Table 3: Replicate transduction mixture set up for Minimal genome-wide human CRISPR Cas9 library. The volume of library virus required to obtain 30% transduction efficiency will be previously established following library titration and scaled to account for transduction labware size at screen.

6.12.

Prepare an un-transduced control using the appropriate volumes of reagents listed in Table 4. Approximately 1.6 x106cells should be seeded into a 50 ml bioreactor tube. 

Table 4: Un-transduced control mixture set up.
Table 4: Un-transduced control mixture set up.
6.13.

Incubate the control bioreactor and replicate flasks prepared in step 6.11 and 6.12 overnight at 37°C5% CO2.

6.2.

Collect the organoid suspension culture from step 3.16 in a 50 ml tube and centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

6.3.

Aspirate the supernatant and resuspend the pellet in 30 ml of TrypLE.

6.4.

Pipette the suspension up and down multiple times to dissociate organoids from the BME2.

6.5.

Incubate at 37°C 5% CO2.

6.6.

Check the organoid suspension under the microscope every 15 minutes to assess and

monitor the dissociation of the organoids. Mix the suspension thoroughly prior to each check to help dissociate the organoids.

Note
Generally the suspension becomes cloudy once the majority of organoids are dissociated to small clumps of cells. Stop the incubation once the organoids have broken down to single cell.

6.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s

6.8.

Aspirate the supernatant and resuspend the pellet in an appropriate volume of organoid specific culture media.

Note
25 -35 ml is advised

6.9.

Perform a cell count to calculate the total number of cells.

Note
For this protocol, using the Minimal genome-wide human CRISPR Cas9 library requires a minimum of 40x106cells at this stage. The number of cells required may vary for transduction using alternative gRNA libraries as the number of cells required at transduction is dependent on library size and required coverage.

7.

Day 2: Plating

7.1.

Collect and transfer the replicate solutions into labelled 50 ml tubes and centrifuge alongside the control bioreactor tube at800x g,0h 0m 0s for0h 2m 0s .

Safety information
Lentiviral vectors can infect human cells. Ensure correct use of PPE and utilise recommended waste routes to reduce the risk.To reduce the risk of aerosols, it is advised where possible that centrifuge buckets are sealed using safety caps and only opened in a microbiological safety cabinet.

7.2.

Aspirate the supernatant and resuspend each replicate pellet in 19mL organoid specific culture media with 5µL of 10millimolar (mM) Y-27632 (Rock inhibitor) and 1mL of BME2 to make a 5% BME2 solution.   

7.3.

Mix the suspension well by gentle pipetting and transfer each replicate into x1 ultra low-attachment T75 flask and incubate at 37°C 5% CO2.

7.4.

For the control sample, aspirate the supernatant from the tube and resuspend the cell pellet in 1.9 ml of organoid specific culture media containing 0.5µL 10millimolar (mM) Y-27632 (Rock inhibitor) and add 100µL of BME2 to make a 5% BME2 solution. 

7.5.

Mix well by pipetting and transfer into 1 well of an ultra-low attachment 6wp and incubate at 37°C 5% CO2.

8.

Day 6: Puromycin selection and flow cytometry analysis.

8.1.

Using a pipette, collect 0.5-1 ml from each replicate and transfer to individual 2 ml tubes. Collect all of the control and transfer to another 2 ml tube, this is done to test infection efficiency using flow cytometry.

8.10.

Incubate at 37°C 5% CO2.

8.2.

Fix each organoid sample and analyse by flow cytometry following steps 5.1 to 5.17.

Note
The un-transduced control once fixed should be kept at 4°C for re-analysis at Day 21-23 (Assessment of final selection efficiency).

8.3.

The pass rate for transduction efficiency is 30%, calculated from step 5.19 . However a value between 15-50% is acceptable. This is to try and ensure only 1 copy of the library has been transduced per cell. If a value outside of this range is obtained at this stage the screen should be failed. (Fig 6). If the pass rate has been reached, continue to step 8.4.

Citation
Fig 6: Example flow cytometry analysis of transduction efficiency for screen replicates showing %BFP expression. Red = transduced replicate. Blue = e780 un-transduced control.
Fig 6: Example flow cytometry analysis of transduction efficiency for screen replicates showing %BFP expression. Red = transduced replicate. Blue = e780 un-transduced control.

8.4.

For each replicate; collect the suspension culture in a 50 ml tube using a stripette or by pouring the suspension.

Note
If pouring the suspension into a 50 ml tube be mindful of the increased contamination risk.

8.5.

Mix the suspension well by pipetting to break down any larger clumps of BME2/aggregates

before centrifugation.

8.6.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

Safety information
Lentiviral vectors can infect human cells. Ensure correct use of PPE and utilise recommended waste routes to reduce the risk.To reduce the risk of aerosols, it is advised where possible that centrifuge buckets are sealed using safety caps and only opened in a microbiological safety cabinet.

8.7.

Aspirate the supernatant and resuspend the pellet in 10mL organoid specific culture media.

8.8.

Prepare the ultra-low attachment T75 flask with the appropriate remaining volume of media, BME2 and puromycin (Table 5 and 6) (Puromycin should be added at a concentration previously calculated in Fig 2).

Note
Ultra-low attachment T75 flasks have a working volume of between 20 - 40 ml. This is dependent on the confluency of the organoid suspension culture.

Safety information
Puromycin is toxic if swallowed, harmful in contact with skin

Table 5: Volumes for preparing 5% BME media solution
Table 5: Volumes for preparing 5% BME media solution
Table 6: Puromycin selection volumes to add per specific total flask volumes.
Table 6: Puromycin selection volumes to add per specific total flask volumes.
8.9.

Mix the cell suspension well by pipetting, then transfer cell suspension to the individual ultra-low attachment T75 flasks.

9.

Day 9-20: Maintenance of screens. (The following steps outline a 1:2 passage)

Note
Media change, or passage 1:2 during week 3 as appropriate. Do not discard any cells at this point and re-seed all at passage.  Screens are maintained in puromycin selection until the point of pellet.

9.1.

Collect suspension for each replicate in 50 ml tubes.

9.2.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

Safety information
Centrifuge buckets must be sealed using safety caps, which must only be opened in a microbiological safety cabinet.

9.3.

Aspirate the supernatant and resuspend the pellet in an appropriate volume of TrypLE.

Note
Small pellets (less than 2 ml in size) can be resuspended in up to 10 ml, whilst larger pellets may need to be resuspended in up to a maximum of 40 ml per tube. 

9.4.

Mix well by pipetting and incubate at 37°C 5% CO2 for 0h 10m 0s.

Note
Check organoid suspension under the microscope after 5 minutes to assess and monitor the dissociation of the organoids. Pipette the cell suspension up and down to help dissociate the organoids. Generally the suspension becomes cloudy once the majority of organoids are dissociated to smaller clumps of cells.

9.5.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

Safety information
Centrifuge buckets must be sealed using safety caps, which must only be opened in a microbiological safety cabinet.

9.6.

Aspirate the supernatant and resuspend each pellet in 20mL organoid specific culture media.

9.7.

Prepare 2x ultra-low attachment T75 flasks with the appropriate remaining volume of media, BME2 and puromycin per replicate (Table 5 and 6).

9.8.

Mix the cell suspension well by pipetting, then transfer half the cell suspension to each new ultra-low attachment T75 flask.

9.9.

Incubate at 37°C 5% CO2.

10.

Day 21-23: Assessment of final selection efficiency

10.1.

Using a pipette, collect 0.5-1 ml from each replicate and transfer to separate 2 ml tubes.

10.2.

Fix each organoid sample and analyse by flow cytometry following steps 5.1 to 5.17.

Note
The un-transduced control, fixed at Day 6 and kept at 4°C should be re-analysed alongside the fixed replicates at Day 21-23.

10.3.

The pass rate for post-puromycin selection is between 60-100%. This ensures efficient selection of organoids that have been transduced with the viral library. If a value below this range is obtained at this stage the screen should be failed. (Fig 7). If the pass rate has been reached continue to step 11.1.

Citation
Fig 7: Example flow cytometry analysis of screen replicates at post-puromycin selection showing %BFP expression. Blue = transduced replicate. Red = e780 un-transduced control.
Fig 7: Example flow cytometry analysis of screen replicates at post-puromycin selection showing %BFP expression. Blue = transduced replicate. Red = e780 un-transduced control.

11.

Day 21-23: Pelleting using Cell Recovery Solution

11.1.

Collect suspension for each replicate in 50 ml tubes.

11.10.

Aspirate the PBS and store the pellets at -80°C ready for downstream processing.

11.2.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

Safety information
Centrifuge buckets must be sealed using safety caps, which must only be opened in a microbiological safety cabinet.

11.3.

Aspirate the supernatant and resuspend each pellet in an appropriate amount of Cell Recovery Solution (up to 30mLper replicate) to remove BME. Mix well by pipetting.

11.4.

Incubate on ice for1h 0m 0s.

11.5.

Once the sample tubes have been on ice for 0h 30m 0s; mix the suspensions well by pipetting and take aliquots from each replicate to perform a cell count.

11.6.

Following 1h 0m 0s on ice, based on the required number of cells per pellet, transfer the required volume of cells per pellet into 15 ml tubes.

Note
For the minimal library used in this example 25x106 cells are recommended per pellet. If more than 15 ml of suspension is required, multiple rounds of centrifugation are advised.

11.7.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

11.8.

Aspirate the supernatant and resuspend in 10 ml of 4°C PBS to wash and remove the Cell Recovery Solution from the pellets.

Note
It is advised to dispense the PBS quickly onto the pellet and to avoid mixing the suspension as the pellet will be prone to sticking to the stripette resulting in a loss of cells.

11.9.

Centrifuge at 800x g,0h 0m 0s for 0h 2m 0s.

推荐阅读

Nature Protocols
Protocols IO
Current Protocols
扫码咨询